By BY EMILY ANTHES from NYT Health https://ift.tt/4iGE6sm
Wednesday, April 6, 2022
A second booster helped protect older people from Omicron infection, but waned quickly, an Israeli study says.
By BY EMILY ANTHES from NYT Health https://ift.tt/4iGE6sm
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
By BY PAM BELLUCK from NYT Health https://ift.tt/w4rPJyW
Tuesday, April 5, 2022
The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.
By BY ADEEL HASSAN from NYT Health https://ift.tt/cHEVJZ2
A second booster helped protect older people from Omicron infection, but waned quickly, an Israeli study says.
By BY EMILY ANTHES from NYT Health https://ift.tt/VwAocG9
Monday, April 4, 2022
The C.D.C. will undergo a comprehensive re-evaluation, the agency’s director said.
By BY RONI CARYN RABIN from NYT Health https://ift.tt/HbFTkdq
Mass distribution of coronavirus tests may have helped blunt the Delta surge in two Michigan cities, a study suggests.
By BY EMILY ANTHES from NYT Health https://ift.tt/kayOwiT
The pandemic has an outsize effect on Americans with diabetes.
By BY ANDREW JACOBS from NYT Health https://ift.tt/OWaw3pH
